Evidence map›Paper›PMID 36393969›Full record

ArticleDisease markers2022

Characteristic Genes and Immune Infiltration Analysis for Acute Rejection after Kidney Transplantation.

Zechao Lu, Fucai Tang, Zhibiao Li, Zhixin Xie, Hanxiong Zheng, Jishen Zhang, Yanchun Gao, Zechu Lu, Yueqiao Cai, Yongchang Lai and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Zechao LuDepartment of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Zhong Road #3025, Futian District, Shenzhen, Guangdong 518033, China.ORCID https://orcid.org/0000-0002-8815-819X
Fucai TangDepartment of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Zhong Road #3025, Futian District, Shenzhen, Guangdong 518033, China.ORCID https://orcid.org/0000-0002-9693-8065
Zhibiao LiDepartment of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Zhong Road #3025, Futian District, Shenzhen, Guangdong 518033, China.ORCID https://orcid.org/0000-0003-2669-7451
Zhixin XieThe Second Clinical College of Guangzhou Medical University, Guangzhou, Guangdong, China.ORCID https://orcid.org/0000-0002-9660-7311
Hanxiong ZhengDepartment of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Zhong Road #3025, Futian District, Shenzhen, Guangdong 518033, China.ORCID https://orcid.org/0000-0002-0045-4833
Jishen ZhangDepartment of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Zhong Road #3025, Futian District, Shenzhen, Guangdong 518033, China.ORCID https://orcid.org/0000-0002-3111-5009
Yanchun GaoThe First Clinical College of Guangzhou Medical University, Guangzhou, Guangdong, China.ORCID https://orcid.org/0000-0002-3509-3361
Zechu LuThe Second Clinical College of Guangzhou Medical University, Guangzhou, Guangdong, China.ORCID https://orcid.org/0000-0002-7659-3717
Yueqiao CaiThe First Clinical College of Guangzhou Medical University, Guangzhou, Guangdong, China.ORCID https://orcid.org/0000-0001-6746-8407
Yongchang LaiDepartment of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Zhong Road #3025, Futian District, Shenzhen, Guangdong 518033, China.ORCID https://orcid.org/0000-0003-2514-4628
Zhaohui HeDepartment of Urology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shennan Zhong Road #3025, Futian District, Shenzhen, Guangdong 518033, China.ORCID https://orcid.org/0000-0003-2289-9603
Sun Yat-sen University · CNGuangzhou Medical University · CNSecond Affiliated Hospital of Guangzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Renal transplantation can significantly improve the survival rate and quality of life of patients with end-stage renal disease, but the probability of acute rejection (AR) in adult renal transplant recipients is still approximately 12.2%. Machine learning (ML) is superior to traditional statistical methods in various clinical scenarios. However, the current AR model is constructed only through simple difference analysis or a single queue, which cannot guarantee the accuracy of prediction. Therefore, this study identified and validated new gene sets that contribute to the early prediction of AR and the prognosis prediction of patients after renal transplantation by constructing a more accurate AR gene signature through ML technology. Methods: Based on the Gene Expression Omnibus (GEO) database and multiple bioinformatic analyses, we identified differentially expressed genes (DEGs) and built a gene signature via LASSO regression and SVM analysis. Immune cell infiltration and immunocyte association analyses were also conducted. Furthermore, we investigated the relationship between AR genes and graft survival status. Results: Twenty-four DEGs were identified. A 5 gene signature (CPA6, EFNA1, HBM, THEM5, and ZNF683) were obtained by LASSO analysis and SVM analysis, which had a satisfied ability to differentiate AR and NAR in the training cohort, internal validation cohort and external validation cohort. Additionally, ZNF683 was associated with graft survival. Conclusion: A 5 gene signature, particularly ZNF683, provided insight into a precise therapeutic schedule and clinical applications for AR patients.

Indexed as

Kidney TransplantationAdultGraft SurvivalHumansKidneyPrognosisQuality of Life

Identifiers

PMID36393969
PMCPMC9646319
OpenAlexW4308428362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.